 Connection
Alan Palestine to Behcet Syndrome
This is a "connection" page, showing publications Alan Palestine has written about Behcet Syndrome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.789 |
|
|
|
-
Palestine AG, Kolfenbach JR, Ozzello DJ. Rheumatologists and Ophthalmologists Differ in Treatment Decisions for Ocular Beh?et Disease. J Clin Rheumatol. 2016 Sep; 22(6):316-9.
Score: 0.539
-
Okada AA, Palestine AG, Kramer M, Jabs DA. Reply to Comment on: Classification Criteria for Beh?et Disease Uveitis. Am J Ophthalmol. 2022 03; 235:339-340.
Score: 0.192
-
Nussenblatt RB, Palestine AG. Cyclosporine: immunology, pharmacology and therapeutic uses. Surv Ophthalmol. 1986 Nov-Dec; 31(3):159-69.
Score: 0.017
-
Chan CC, Palestine AG, Nussenblatt RB, Roberge FG, Benezra D. Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet's disease, and sympathetic ophthalmia. Ophthalmology. 1985 Aug; 92(8):1025-8.
Score: 0.016
-
Nussenblatt RB, Palestine AG, Chan CC, Mochizuki M, Yancey K. Effectiveness of cyclosporin therapy for Beh?et's disease. Arthritis Rheum. 1985 Jun; 28(6):671-9.
Score: 0.015
-
Amital H, Klemperer I, Blank M, Yassur Y, Palestine A, Nussenblatt RB, Shoenfeld Y. Analysis of autoantibodies among patients with primary and secondary uveitis: high incidence in patients with sarcoidosis. Int Arch Allergy Immunol. 1992; 99(1):34-6.
Score: 0.006
-
Nussenblatt RB, Palestine AG, Rook AH, Scher I, Wacker WB, Gery I. Treatment of intraocular inflammatory disease with cyclosporin A. Lancet. 1983 Jul 30; 2(8344):235-8.
Score: 0.003
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|